Data is at the core of everything we do.
Impact we measure: We measure how our seeds affect farmers’ incomes, climate resilience, and the amount of additional nutrition in the maize they consume and sell to others.
Third-party studies: We estimate our impact by correlating these numbers with randomized controlled trials and other studies that we’ve supported or already existed.
Cost-effectiveness: We pull all of these numbers together to estimate how cost-effective our program is. We think if the people you’re trying to help would get more benefit from your NGO being canceled and the budget just donated to them, you should probably just do that.
In-depth reviews of our data are available in our annual reports. We provide data sets upon request, and we’re working to upload our data sets, protocols, and tools to the Harvard Dataverse.
IMPACT SUMMARY
THIRd-party studies
We’d love to measure how the consumption of our maize directly affects health and nutrition impacts (such as stunting) for every family benefiting from our program.
Unfortunately, gathering statistically significant data would require millions of dollars annually in costs (imagine matching weekly maize nutrition and consumption data and quarterly measurements of children in thousands of families).
Instead, we rely on already existing studies and randomized controlled trials that show the nutrition and health impacts of biofortified maize. Where additional studies are needed, we fund and support them.
Already existing studies:
- Gunaratna et al., 2008: Meta-analyses show quality protein maize improves the rate of child growth in height and weight.
- Chomba et al., 2015: Zinc from biofortified maize is as absorbable as zinc from fortified flour.
- INCAP, 2021: Diet recalls indicate that farming households consuming biofortified maize meet most of their daily zinc requirements.
- Cornell & INCAP, 2022-2023: High-zinc maize improved zinc biomarkers in women and children compared to conventional maize. (To be submitted for peer-review in Feb, 2026)
- CU Denver & INCAP, 2024-5 (in progress): An RCT on bioavailability with UC Denver is assessing how tortillas made from biofortified maize affect zinc and iron absorption in Guatemalan children.
Cost-effectiveness
Our most recent internal cost-effectiveness analysis placed our impact at 20x cash transfers, with a cost per DALY of $88.
We’re working on strategies to become 10-20 times more cost-effective than we currently are.
We will periodically release updated cost-effectiveness analyses based on new data from our third party studies, new modeling, our costs, and our annual reach of farmers.